Recent advances of antibody drug conjugates for clinical applications - ScienceDirect
World ADC Summit 2019: Bioanalysis Day summary | Bioanalysis Zone
Antibody–drug conjugates for cancer - The Lancet
11 FDA Approved Antibody-Drug Conjugates: An Overview | Biochempeg
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology
How Far We Have Advanced in the Chemotherapy World - IBL America Online Store
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
The Role of Organic Synthesis in the Emergence and Development of Antibody–Drug Conjugates as Targeted Cancer Therapies - Nicolaou - 2019 - Angewandte Chemie International Edition - Wiley Online Library
NJ BIO — Recent Advances in ADCs
NJ BIO — Recent Advances in ADCs
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Frontiers | The Analysis of Key Factors Related to ADCs Structural Design | Pharmacology
Antibody–Drug Conjugates: Perspectives and Characterization
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Antibody–Drug Conjugates: Perspectives and Characterization
Araris Biotech
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology